Antiemetics Market – Size, Share, Growth, Trends, and Regional Outlook by 2025

 Key Players

Some of the key players in the Global Antiemetics Market are GSK (UK), Merck (US), Sanofi-Aventis (France), Pfizer Inc. (US), Mylan (US), Eli Lilly and Company (US), Johnson & Johnson (US), Baxter International (US), Dr. Reddy's Laboratories Inc. (India) and others.

Market Highlights

According to MRFR analysis, Antiemetics Market is expected to register a CAGR of 6.6% during the forecast period of 2019 to 2025 and account for USD 6.7 Billion in 2025.

The Global Antiemetics Market is expected to grow at a steady pace. There are numerous antiemetics agents available for the treatment of nausea and vomiting, including; dopamine antagonists, anticholinergics, antihistamines, serotonin antagonists, and others. The key players manufacturing these products include GSK, Merck, and Pfizer Inc. As these players generate their maximum revenue from the Americas for the market, the region accounted for significant share across the globe.

The market is expected to grow at a steady growth rate. The significant factors influencing the growth of the market include increasing investment in the pharmaceutical industry, increasing the number of postoperative procedures, pregnancy-induced nausea, and acute gastroenteritis, further influencing the growth of the market. Moreover, the rising demand for novel therapeutics and the increasing prevalence of postoperative nausea and vomiting (PONV) is responsible for positive market growth.  

 

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/antiemetics-market-8454 

Regional Analysis

On a regional basis, the Americas are anticipated to dominate the global antiemetics market owing to the growing clinical research & development budgets by both public and private organizations in the pharmaceutical industry, increasing demand for novel therapeutics and the abundant presence of significant manufacturer in the region. Additionally, rising postoperative procedures is expected to influence the growth of the market. According to a study, it is found that PONV occurs in nearly 30% of the general surgical population and up to 70% to 80% of high-risk surgical patients. Europe is expected to account for the second-largest market in the global antiemetics market owing to well-developed research infrastructure, increasing healthcare awareness in the region, and high expenditure in pharmaceutical research.

Segmentation

The Global Antiemetics Market has been segmented into agents, drug type, application, and distribution channel.

By agents, the market has been segmented into dopamine antagonists, anticholinergics, antihistamines, serotonin antagonists, cannabinoids, and others. Furthermore, dopamine antagonists is segmented into phenothiazines (chlorpromazine, prochlorperazine), butyrophenones (droperidol, domperidone ), and benzamides. Moreover, serotonin antagonists is further divided into ondansetron, granisetron. The others segment includes dexamethasone and propofol. Dopamine accounted for the largest market share majorly due to FDA approval for the maximum number of application

By drug type, the market is segmented into prescribed and OTC. Prescribed drugs accounted for the large share by drugs type due to the high cost of the drugs when compared to OTC and also are most prescribed by the professionals.

Based on application, the market is segmented into chemotherapy, motion sickness, stomach flu, pregnancy, postoperative surgery, and others. Postoperative surgery accounted for the largest market share on the basis of attributing to an increasing number of surgery procedures and mandatory postoperative procedures for the same.

The global antiemetics market, by distribution channel, has been a retail pharmacy, hospital pharmacy, online. On the basis of distribution channel, retail pharmacies accounted for the largest share due to the presence of a large number of retail pharmacies across the globe.

Moreover, rising healthcare expenditure is boosting the market in this region. Asia-Pacific is expected to be the fastest-growing region due to the growing interest of major key players in entering emerging markets, increasing development in the pharmaceutical industry in this region. Moreover, increasing the adoption of chemotherapy for the treatment of cancer expected to influence the growth of the market. The Middle East & Africa is expected to account for the least share of the global antiemetics market. Moreover, the significant market share of the region is expected to be held by the Middle East region owing to the increasing investment by major manufacturers and changing healthcare reforms.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Healthcare Fraud Detection Market Prevalence of Periodontal Diseases | Size, Share, analysis, Growth, Global Industry Overview and Forecast to 2024

 Global Healthcare Fraud Detection Market: Information By Type (Descriptive Analytics, Predictive Analytics and Prescriptive Analytics), By Component (Services and Software), By Delivery Model (On-Premise and Cloud-Based), By Application (Insurance Claims Review and Payment Integrity), By End User (Private Insurance Payers, Public/Government Agencies and Third Party Service Providers) - Forecast till 2024

 

Healthcare Fraud Detection Market Overview

 

The healthcare fraud detection market is anticipated to grow by US$3,787.68 Million by 2024 rapidly growing at a CAGR of 28.83% during the forecast period. The global healthcare fraud detection market is driven by expanding patient populations opting for healthcare insurance. 

Free Sample Copy with Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/5670 

These factors have helped shape the healthcare fraud detection market and are expected to boost the growth. Companies in the healthcare fraud detection market could also face challenges such as low awareness level in emerging countries and lack of skilled human resources. The details covered in the healthcare fraud detection market report cover all the aspects of the industry. Healthcare fraud detection market analysts have also shared growth projections in the report and have suggested healthcare fraud detection market players to plan growth strategies accordingly.

 

Healthcare Fraud Detection Market Segmentation

 

The global healthcare fraud detection market has been segmented based on type, application, component, end-users, and delivery model. On the basis of type, the market for healthcare fraud detection is segmented based on descriptive analytics, predictive analytics, and prescriptive analytics. Additionally, the market on the basis of components, is segmented into services and software. The global market for healthcare fraud detection is also covered based on the end-users segment which is further split into private insurance payers, public/government agencies, and third party service providers. On the basis of delivery model, the market for healthcare fraud detection is segmented based on on-premise and cloud-based. Additionally, the market on the basis of XXX, is segmented into insurance claims review and payment integrity. 

 

Factors like surge in suspicious cases in the healthcare sector and growing demand to track healthcare fraud and abuse support the healthcare fraud detection market growth. The performance of the healthcare fraud detection market has also been studied for the past and current years. Additionally, the healthcare fraud detection market report provides analysis of these segments. The healthcare fraud detection market segmental analysis provided in the report offers major details about the healthcare fraud detection market performance and future.

 

Healthcare Fraud Detection Market Regional Overview

 

Companies in the healthcare fraud detection market are spread across the world. The healthcare fraud detection market report provides major information about regional markets of North America, Europe, Asia-Pacific (APAC), and the rest of the world. The North American healthcare fraud detection market has many companies across the United States, Canada, and Mexico. Europe has companies in the healthcare fraud detection market across Germany, France, Spain, Italy, and the United Kingdom. A detailed analysis of the healthcare fraud detection market across India, China, and Japan in the Asia-Pacific region is also presented in the report. The healthcare fraud detection market of the Middle East, Africa, and other regions has also been studied by analysts. The regional analysis of the healthcare fraud detection market can be found in the market research report.

 

Healthcare Fraud Detection Market Competitive Landscape

 

The healthcare fraud detection market is supported by the growing number of healthcare BPO and arrival of software tools to curb fraud activities. The population growth around the world and increasing demand of healthcare fraud detection market based services and products also support the market growth. However, the healthcare fraud detection market growth can be affected due to reluctance for change. The report covers all such details which will help companies in the healthcare fraud detection market to strengthen their business plan and improve their product portfolio. The healthcare fraud detection market research report also provides company profiles of major companies. The company profiles of many organizations operating in the healthcare fraud detection market report highlights crucial details like company size, revenue growth, and details of mergers and acquisitions taking place in the healthcare fraud detection market. New companies and established businesses can plan their strategies based on this data provided in the healthcare fraud detection market research report.

 

Industry News

 

Equifax has entered into a contract for $640 million to acquire artificial intelligence powered fraud detection and data security solutions company Kount. The teams of Kount might become part of the business division of Equifax's United States Knowledge Solutions (USIS) but will still be centered in Boise, Idaho, per an update shared by the company.

 

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/healthcare-fraud-detection-market-5670 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Cardiac Resynchronization Therapy Market – Global Demand, Sales,COVID-19 Impact Analysis, Consumption and Forecasts to 2023

 Global Cardiac Resynchronization Therapy (CRT) Market Research Report: By Application (Intraventricular dyssynchrony, Interventricular (V-V) dyssynchrony), By Type (CRT-P, CRT-D) and By End-User (Hospitals, Cardiac Specialty Centers, Academic and Research Organizations) – Forecast to 2025

Market Highlights

According to MRFR analysis, the Global Cardiac Resynchronization Therapy Market is expected to register a CAGR of 5.50% during the forecast period of 2019 to 2025 and was valued at USD 4.7 Million in 2025 to USD 4.7 Billion in 2025.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8357 

Cardiac resynchronization therapy is also known as biventricular pacing, it used to aid in correcting the heart’s rhythm and any symptoms associated with irregular heart rhythms (arrhythmias). In this procedure implantation of a pacemaker is done, with three wires attached to the device to monitor the heart rate irregularities and can emit small pulses of electricity to correct them, and therefore it’s called resynchronizing the heart.

The growth of global cardiac resynchronization therapy market is driven by various factors such as a growing number of intensive care units, a rising number of surgical procedures, and rising sedentary lifestyle followed by poor fitness levels. However, the high costs of therapy are expected to curb the growth of the global cardiac resynchronization therapy market.

The global cardiac resynchronization therapy market is currently dominated by several market players. The key players are involved in innovative product launches and strategic alliance to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of cardiac diseases and rising per capita healthcare expenditure. The cardiac resynchronization therapy market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European cardiac resynchronization therapy market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The cardiac resynchronization therapy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing surgical procedure and rising awareness about cardiac resynchronization therapy (CRT) devices, the market in Asia-Pacific is expected to be the fastest-growing. The cardiac resynchronization therapy market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The global cardiac resynchronization therapy market has been segmented based on application, type, and end user. The market, based on application, has been divided into intraventricular dyssynchrony, interventricular (V-V) dyssynchrony, and atrioventricular (A-V) dyssynchrony. The intraventricular dyssynchrony segment is likely to be the largest during the review period due to the growing prevalence rate of heart diseases followed by, increasing demand for invasive procedures globally. In year 2018, a study showed nearly 78,000 and 116,000 people are suffering from atrial fibrillation (a type of abnormal heart rhythm) in France and Germany, respectively.

The atrioventricular (A-V) dyssynchrony segment is predicted to be the fastest-growing due to the rising geriatric population.  The global cardiac resynchronization therapy market has been segmented, on the basis of type, into cardiac resynchronization therapy pacemaker (CRT-P), and cardiac resynchronization therapy defibrillator (CRT-D). The CRT-P segment is expected to hold the majority share of the market. In 2018, a study showed in a group of 200 people 52.2% used CRT-P for arrhythmias related problem, and 47.5% people used for atrioventricular blockage treatment. The end user segments of the market are hospitals, cardiac specialty centers, and academic and research organizations. The hospitals segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving the therapy.

Key Players

Some of the key players in the global cardiac resynchronization therapy market are Medtronic (Ireland), BIOTRONIK, Inc. (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), Shree Pacetronix Ltd. (India), Medico S.p.A. (Italy), Abbott (US), and Lepu Medical Technology Co., Ltd. (China).

Access Report Details @ https://www.marketresearchfuture.com/reports/cardiac-resynchronization-therapy-market-8357 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Hormonal Implants Market (2021-2025) Analysis with Upcoming Trends and Opportunities

 Market Highlights

The Global Hormonal Implants Market is estimated to have a positive growth at the CAGR of ~5.0% during the forecast period of 2019–2025.

A study observed that no pregnancy was observed in a group of certain women using hormonal implants for five years. Safety from unwanted pregnancies and suitable government programmers are the major factors driving the market growth.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8242    

However, cases of side-effects related to hormonal contraceptives, pricing variations, and limited availability of the product are restraining the growth of the market during the assessment period is hindering the growth of the global hormonal implants market in the forecast period.

Global, as well as local players, are present in the hormonal implants market. A majority of the market is currently held by global players like Allergan. In May 2016, ALLERGAN took an initiative to help the US military servicewomen to access LILETTA under the Federal Supply Schedule (FSS) price of USD 55.83 to educate these servicewomen about the importance of contraception.

Key Players

Some of the key players in the global hormonal implants market are Shanghai Dahua Pharmaceuticals Co., Merck & Co., Inc., Bayer HealthCare, Ltd and Allergan.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/hormonal-implants-market-8242 

Regional Analysis

The global hormonal implants market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hormonal implants market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European hormonal implants market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been segmented as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hormonal implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hormonal implants market in the Middle East & Africa has been divided into the Middle East and Africa. 

Segmental Analysis

The global hormonal implants market has been segmented based hormone, type, distribution sector, end user, and region.

The market, based on hormone, has been bifurcated into levonorgestrel and etonogestrel. The levonorgestrel segment is anticipated to hold the largest share in the market, market due to the wider preferability and longer durability compared to other contraceptives for the use of hormonal implants.

The market, based on the distribution sector, has been segmented into the public sector and private sector. The public sector market is expected to hold the largest share in the market, due to increasing adoption rates in public healthcare facilities under various government regulations.

The market, by end-user, has been divided into hospitals & clinics, academic & research institutes. The hospitals & clinics segment is expected to lead the market, due to the major commercialization is done through them.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Veterinary Imaging Market, Size, Share, and Growth, Trends, Industry Analysis, Key Player profile and Regional Outlook by 2023

 Market Research Future published a Half-Cooked Research Report on “Global Veterinary Imaging Market Research Report - Forecast to 2023”– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Global Veterinary Imaging Market  - Overview

The global veterinary imaging market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Veterinary deals with diagnosis and treatment of diseases in animals. Veterinary imaging devices are useful in diagnosis and treatment of diseases in animals. These devices also gives clear understanding of disease or injury that helps veterinarian for treatment of animal. Increasing awareness about animal healthcare and improvement of animal life are key factors for the growth of the market. Disease pattern in animals are continuously changing and becoming more challenging for veterinarians to diagnose these diseases. Veterinary imaging devices gives them in accurate diagnosis and further treatment. Increasing pet adoption is another major factor for the growth of the market. Increasing number of veterinarians, veterinary clinics and growing veterinary healthcare infrastructure are driving the growth for the market. Cattle are very important part of farming that have economic importance because they provides many products like milk, meat and leather. Farmers are becoming more aware about the health of their cattle which is good sign for the growth of the market. About 75% of veterinarians are working in private hospitals or pet clinics and these hospitals or clinics are spending money in advancement of technology to provide better facilities. Veterinary imaging devices manufacturers are spending money to develop innovative and usable product for the market. However there are some factors are inhibiting the growth of the market such as high cost of devices that small clinics cannot afford, lack of knowledge about new technology or products, availability of products, access to veterinary healthcare facilities, lack of skilled veterinary professionals etc.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2919

Top Companies: 

Atlantis Worldwide (US), Canon Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Hitachi, Ltd (Japan), Medical Imaging / IMCO, Inc. (US), Sectra (Sweden), Siemens AG (Germany), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Veterinary Imaging Market and are profiled in MRFR Analysis. 

Global Veterinary Imaging Market  - Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of veterinary imaging appears to be highly competitive and fragmented. Major market players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The Market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers. Therefore, key players ensure that their portfolio includes products both for treating sick animals and for preventing disease occurrence.

December, 2015 - Fujifilm and Anicom Holdings, Inc. entered into partnership and established joint venture for developing and providing cutting-edge veterinary technologies and services with focus on regenerative medicine. According to company reports, it had developed advanced veterinary medicine by combining Fujifilm's advanced production engineering and quality control technology nurtured in its photographic film business as well as diagnostic imaging technology, blood's chemical composition analysis technology and regenerative medical technology, with Anicom's veterinary hospital network, electronic medical record system and extensive animal treatment data. Moreover, the company had conducted science-based clinical research such as regenerative medicine including cell therapies.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Global Veterinary Imaging Market - Regional Analysis

Depending on geographic region, veterinary imaging market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America holds be the largest market for veterinary imaging due to increasing awareness about animal healthcare and increasing investment in healthcare domain. Moreover the European market is also growing and second largest market for Veterinary Imaging. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the Veterinary Imaging during the forecasted period. Whereas, The Middle East & Africa have the least market share. Additionally, factors such as lack of awareness, low healthcare expenditures will restrain the market during the corresponding period.

Report Details @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

 

Elastography Imaging Market 2021 Share, Emerging Technologies, Regional Analysis, Competitive Landscape and Forecast to 2025

 Elastography Imaging Market Analysis 

The global elastography imaging market is estimated to grow at an 11.1% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. Elastography, simply put, is a medical imaging mode that maps the stiffness & elastic properties of soft tissue. Owing to its magnificent features, elastography imaging has wide applications in orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8070 

Numerous factors are adding to the global elastography imaging market growth. Such factors, according to the recent MRFR report, include the growing demand for effective therapies for treating complicated disorders, changes in regulatory policies, increasing incidence of life-threatening diseases, and burgeoning demand for procedures that are minimally invasive to diagnose as well as treat various chronic diseases. 

On the contrary, the high price of systems may limit the global elastography imaging market growth over the forecast period. 

Market Segmentation

The MRFR report provides an inclusive segmental analysis of the global elastography imaging market based on end user, application, and modality. 

By modality, the elastography imaging market is segmented into magnetic resonance elastography (MRI) and ultrasound. Of these, the ultrasound segment will lead the market over the forecast period for the plentiful benefits that it offers. Meanwhile, magnetic resonance elastography will grow at the fastest pace for its increasing adoption rate and wider availability. 

By application, the elastography imaging market is segmented into orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others. Of these, radiology/general imaging will dominate the market over the forecast period for the rising prevalence of chronic diseases worldwide. Meanwhile, the cardiology segment will grow at the fastest pace over the forecast period for the increase in the patient population. 

By end user, the elastography imaging market is segmented into research laboratories, diagnostic centers, hospitals and ambulatory surgical centers, and others. Of these, hospitals and ambulatory surgical centers will have a major share in the market over the forecast period. Rising number of hospitals coupled with the increasing number of hospitalizations are adding market growth. Meanwhile, the diagnostic centers will grow at the fastest pace over the forecast period for inclination towards these centers and increased patient preference. 

Regional Analysis 

By region, the global elastography imaging market report covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will have the lions share in the market over the forecast period. Factors adding to the global elastography imaging market growth in the region include the increasing use of new technology, rising per capita healthcare expenditure, and increasing expenditure by healthcare bodies in research. Canada and the United States are the key contributors in the region for improving reimbursement scenario and a rise in insurance coverage. 

The global elastography imaging market in Europe is predicted to hold the second-largest share over the forecast period for the involvement of top companies, rise in chronic diseases, and the presence of an established healthcare system. 

The global elastography imaging market in the APAC region will have steady growth over the forecast period for the favorable initiatives undertaken by the government for healthcare reforms and the rising prevalence of chronic diseases. Meanwhile, a fall in capital investment may hinder the market growth. 

The global elastography imaging market in the MEA will have a small share during the forecast period for the region’s low disposable income and limited access to medical treatment facilities. 

Key Players

Leading players profiled in the global elastography imaging market report include General Electric Company, Supersonic Imagine, Samsung Electronics (Samsung Medison), Koninklijke Philips N.V., Mindray Medical International Ltd., Resoundant Inc., Hitachi Ltd., Esaote, Fujifilm Holdings Corporation, Siemens AG, and Canon Medical Systems Corporation. 

Industry News

November 2019: SimonMed Imaging is the first to provide advanced screening for fatty liver disease. The VIDA 3T MRI helps to detect fibrosis resulting from fatty liver disease or other chronic liver diseases. It uses MRE (magnetic resonance elastography) that combines sound waves with MRI to develop an elastogram (visual map) to show the stiffness of the body tissue, thus offering radiologists with color contrasted clear visual, maximizing accuracy, and limiting error.

Browse Complete Report With Toc@ https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Cardiovascular Information System (CVIS) Market Share 2021 COVID-19 Pandemic Impact, Segmentation and Comprehensive Analysis till 2025

 Overview

The global cardiovascular information system (CVIS) market size is poised to reach the valuation of USD 1,343.26 million by 2025, as per the latest report by Market Research Future (MRFR). The market can grow immensely at 8.30% CAGR over the forecast period (2018-2025).

High prevalence of cardiovascular diseases (CVDs) and disorders is the primary driver of the market. As per the 2015 report by the World Health Organization (WHO), nearly 17.7 million died as a result of CVDs. This has triggered the need for advanced systems in hospitals to reduce the mortality rate. In addition, government initiatives to digitize patient data is likely to bode well for the cardiovascular information system (CVIS) market. Implementation of the electronic health records (EHR) system can make it easy for doctors and physicians to lead to faster diagnosis of diseases.

Technological developments in healthcare IT has led to the launch of CVIS platforms which can be accessed remotely. This offers scope for doctors to diagnose and prescribe accurate suggestions to patients. Recent upgrades to CVIS has made it possible for different departments in the cardiology section to share and exchange information on a single platform.

The high costs associated with CVIS which can lead to hesitation towards adoption among hospitals can pose a challenge to the market growth.

Segmentation Analysis

The cardiovascular information system (CVIS) market is segmented by component, deployment, application, and end-user.

By component, software held close to 67.9% share of the CVIS market in 2017, followed by services the second largest market and hardware the least market share. The software segment is expected to reach a valuation of USD 930.65 million by 2025 due to the software being able to provide clinical data to patients and doctors in real-time. Services, on the other hand, can aim to grow at a steady pace by the end of the forecast period due to constant maintenance and upgradation of CVIS to ensure a smooth workflow in clinics and hospitals.

By deployment, web/cloud-based held the largest market share in 2017, while the on-premise segment held second largest share. The web/cloud-based CVIS is projected grow at fastest CAGR during the forecast period due to low capital investment and scalability of operations. In addition, the ease it provides in reporting information and causing minimal clinical efficiencies can lead to its adoption. On the other hand, on-premise segment accounted for the least market share due to high expenses in maintaining servers, software, and hardware.

Among applications, cardiac and peripheral catheterization held 32.4% share in 2017, followed by echocardiography, hemodynamics monitoring, electrophysiology, vascular ultrasound, nuclear cardiology, ECG/stress/Holter management, and others. Cardiac and peripheral catheterization can increase its market share by the end of the forecast period due to its extensive use in early diagnosis and treatment of congenital disorders. On the other hand, echocardiography is predicted to attain second largest share, this can be attributed to its utilization in detecting abnormal heart valves and other heart defects.

Hospitals & clinics was the biggest market end-user in 2017 with a respectable 48.2% share, followed by diagnostic laboratories, cardiac cath labs, and others. Hospitals & clinics can reach a value of USD 640 million by 2025 due to adoption of advanced diagnostic systems for treating CVDs. Diagnostic laboratories generated second largest share for the cardiovascular information system (CVIS) market by 2025. This can be credited to demand by patients for rapid diagnosis solutions.

You can also read Here@ https://www.medgadget.com/2019/10/latest-research-on-cardiovascular-information-system-cvis-market-2019-global-industry-size-share-regional-trends-development-strategy-competitor-analysis-opportunities-complete-study.html 

Regional Analysis

Region-wise, the cardiovascular information system (CVIS) market covers the upcoming trends in Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA). The Americas accounted for 37.6% market share in 2017, followed by Europe, APAC, and MEA.

The Americas CVIS market is expected to reach a valuation of USD 481.04 million by 2025. This can be attributed to sophisticated healthcare infrastructure and adoption of latest systems for streamlining workflow in hospitals. The use of mHealth and big data for detecting CVDs at a preventive stage by clinicians is projected to augur well for the market.

Europe, on the other hand, is predicted to grow at a steady pace due to increased funding by governments and private organizations to improve treatment facilities in cardiology departments in hospitals. Moreover, digitization of patient data is expected to be a positive indicator for the growth of the market.

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/cardiovascular-information-system-market-7721

Competitive Analysis

Key vendors in the cardiovascular information system (CVIS) market include Carestream Health (U.S.), Scimage, Inc. (U.S.), Koninklijke Philips N.V. (The Netherlands), Cerner Corporation (U.S.), Epic Systems Corporation (U.S.), Digisonics Inc. (U.S.), Fujifilm Holdings Corporation (Japan), LUMEDX (China), Agfa-Gevaert N.V. (Belgium), IBM Health (U.S.), General Electric Company (U.S.), McKesson Corporation (U.S.), and Siemens Healthineers (Germany).

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com